Interleukin-1 and interleukin-1 antagonism

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Interleukin-1 (IL-1) is a central pro-inflammatory cytokine impacting numerous physiological systems.
• It plays a dual role in host defense and mediating inflammatory diseases.
• Overproduction of IL-1 can impair normal host functions, making it a therapeutic target.

Purpose of the Study:

• To review the structure, gene expression, synthesis, secretion, and biologic activities of IL-1.
• To discuss IL-1 receptors, signal transduction, and its role in disease.
• To compare IL-1 with other cytokines like TNF and IL-6 and explore therapeutic strategies.

Main Methods:

• Review of existing literature on IL-1 biology, including animal studies and human recombinant IL-1 administration.
• Analysis of IL-1 structure, gene expression, synthesis, and secretion pathways.
• Examination of IL-1 receptor interactions and signal transduction mechanisms.

Main Results:

• IL-1 exhibits fundamental properties as both a mediator of disease and a promoter of host defense.
• Excessive or continuous IL-1 production leads to debilitation of normal host functions.
• The naturally occurring IL-1 receptor antagonist (IL-1ra) effectively blocks IL-1 receptor activation without agonist effects.

Conclusions:

• IL-1ra has demonstrated efficacy in reducing disease severity in various conditions, including sepsis and arthritis.
• Targeting IL-1 synthesis or its effects, especially via IL-1ra, presents promising therapeutic avenues.
• Understanding IL-1's multifaceted roles is crucial for developing effective treatments for inflammatory diseases.